Therapeutic efficiency of platelet gel for the treatment of oral ulcers related to chronic graft versus host disease after allogeneic haematopoietic stem cell transplantation.

about

Therapeutic efficiency of platelet gel for the treatment of oral ulcers related to chronic graft versus host disease after allogeneic haematopoietic stem cell transplantation.

Item

http://www.wikidata.org/entity/Q55183614

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Therapeutic efficiency of plat ...... tic stem cell transplantation.

@en

Therapeutic efficiency of plat ...... tic stem cell transplantation.

@nl

type

Item

label

Therapeutic efficiency of plat ...... tic stem cell transplantation.

@en

Therapeutic efficiency of plat ...... tic stem cell transplantation.

@nl

prefLabel

Therapeutic efficiency of plat ...... tic stem cell transplantation.

@en

Therapeutic efficiency of plat ...... tic stem cell transplantation.

@nl

P1476

Therapeutic efficiency of plat ...... tic stem cell transplantation.

@en

P2093

A Lanti

http://www.w3.org/2001/XMLSchema#string

A Picardi

http://www.w3.org/2001/XMLSchema#string

A S Ferraro

http://www.w3.org/2001/XMLSchema#string

F Meconi

http://www.w3.org/2001/XMLSchema#string

G Adorno

http://www.w3.org/2001/XMLSchema#string

M Miranda

http://www.w3.org/2001/XMLSchema#string

P Bollero

http://www.w3.org/2001/XMLSchema#string

W Arcese

http://www.w3.org/2001/XMLSchema#string

P2860

Allogeneic hematopoietic cell transplantation: the state of the art

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.

Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing.

Advances in understanding the pathogenesis of graft-versus-host disease.

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Algorithm for donor selection in 2011.

The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy.

Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis.

P304

398-405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.11138/ORL/2017.10.4.398

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29682257

http://www.w3.org/2001/XMLSchema#string

P932

5892654

http://www.w3.org/2001/XMLSchema#string